Download presentation
Presentation is loading. Please wait.
Published byJörgen Lundqvist Modified over 5 years ago
1
Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC JAAD Case Reports Volume 2, Issue 4, Pages (July 2016) DOI: /j.jdcr Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 A and B, Cutaneous lesions before intralesional rituximab. C and D, The result after the last treatment cycle. JAAD Case Reports 2016 2, DOI: ( /j.jdcr ) Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.